Sam-A Pharm. Statistics

Total Valuation

Sam-A Pharm. has a market cap or net worth of KRW 98.08 billion. The enterprise value is 34.31 billion.

Market Cap	98.08B
Enterprise Value	34.31B

Important Dates

The last earnings date was Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	6.10M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	68.45%
Owned by Institutions (%)	n/a
Float	1.93M

Valuation Ratios

The trailing PE ratio is 4.44.

PE Ratio	4.44
Forward PE	n/a
PS Ratio	1.03
PB Ratio	0.45
P/TBV Ratio	0.45
P/FCF Ratio	5.24
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.23, with an EV/FCF ratio of 1.83.

EV / Earnings	1.55
EV / Sales	0.36
EV / EBITDA	1.23
EV / EBIT	1.46
EV / FCF	1.83

Financial Position

The company has a current ratio of 5.51, with a Debt / Equity ratio of 0.06.

Current Ratio	5.51
Quick Ratio	4.80
Debt / Equity	0.06
Debt / EBITDA	0.45
Debt / FCF	0.69
Interest Coverage	45.46

Financial Efficiency

Return on equity (ROE) is 10.50% and return on invested capital (ROIC) is 6.87%.

Return on Equity (ROE)	10.50%
Return on Assets (ROA)	6.37%
Return on Invested Capital (ROIC)	6.87%
Return on Capital Employed (ROCE)	10.72%
Revenue Per Employee	318.60M
Profits Per Employee	73.60M
Employee Count	300
Asset Turnover	0.40
Inventory Turnover	2.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.52% in the last 52 weeks. The beta is 0.33, so Sam-A Pharm.'s price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-1.52%
50-Day Moving Average	16,305.80
200-Day Moving Average	20,762.40
Relative Strength Index (RSI)	44.51
Average Volume (20 Days)	10,931

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sam-A Pharm. had revenue of KRW 95.58 billion and earned 22.08 billion in profits. Earnings per share was 3,618.00.

Revenue	95.58B
Gross Profit	60.65B
Operating Income	24.47B
Pretax Income	29.27B
Net Income	22.08B
EBITDA	28.73B
EBIT	24.47B
Earnings Per Share (EPS)	3,618.00

Full Income Statement

Balance Sheet

The company has 76.66 billion in cash and 12.89 billion in debt, giving a net cash position of 63.77 billion or 10,449.02 per share.

Cash & Cash Equivalents	76.66B
Total Debt	12.89B
Net Cash	63.77B
Net Cash Per Share	10,449.02
Equity (Book Value)	219.98B
Book Value Per Share	36,057.00
Working Capital	92.58B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.25 billion and capital expenditures -6.51 billion, giving a free cash flow of 18.74 billion.

Operating Cash Flow	25.25B
Capital Expenditures	-6.51B
Free Cash Flow	18.74B
FCF Per Share	3,069.67

Full Cash Flow Statement

Margins

Gross margin is 63.46%, with operating and profit margins of 25.60% and 23.10%.

Gross Margin	63.46%
Operating Margin	25.60%
Pretax Margin	30.62%
Profit Margin	23.10%
EBITDA Margin	30.06%
EBIT Margin	25.60%
FCF Margin	19.60%

Dividends & Yields

This stock pays an annual dividend of 750.00, which amounts to a dividend yield of 4.69%.

Dividend Per Share	750.00
Dividend Yield	4.69%
Dividend Growth (YoY)	6.67%
Years of Dividend Growth	3
Payout Ratio	20.73%
Buyback Yield	0.01%
Shareholder Yield	4.70%
Earnings Yield	22.51%
FCF Yield	19.10%

Dividend Details

Stock Splits

The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.

Last Split Date	Dec 29, 2008
Split Type	Forward
Split Ratio	1.02005

Scores

Sam-A Pharm. has an Altman Z-Score of 4.82.

Altman Z-Score	4.82
Piotroski F-Score	n/a